Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Who benefites most of the current share price situation?

Who benefites most of the current share price situation?

posted on Nov 18, 2008 10:24PM

Waht I don't get is who has an advantage of such low share prices. Options are mainly based on a higher share price level, bought shares from the buy-back programm are less worth, 100 mio. new sahares.................

The story turns out to me as a big big ?

S402005



Share
New Message
Please login to post a reply